The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter.
The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible.
Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.
All content for Strategy& Insider is the property of Thomas Solbach, Ghioia Irritier, Jan-Philipp Loch and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter.
The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible.
Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.
Strategy& Insider Episode 32 - Making stem cell production accessible
Strategy& Insider
34 minutes
7 months ago
Strategy& Insider Episode 32 - Making stem cell production accessible
In this episode, we welcome two trailblazers in the field of stem cell research: Join Prof. Dr. Katarina Le Blanc, a leading expert with over two decades of experience, as she shares her groundbreaking work with stem cells and how her research has contributed to the mission of making stem cell treatments and research more accessible through Cellcolabs. Accompanying her is Dr. Mattias Bernow, CEO of Cellcolabs, who brings a unique blend of medical and business expertise to the conversation, revealing strategies to make these revolutionary therapies affordable. Tune in to explore the transformative potential of stem cell research in disease care and prevention.
Strategy& Insider
The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter.
The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible.
Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.
